Priority Date: 01.07.10 (US 20100360626P)

ISOINDOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

  • Application ID: EP11801342
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck Sharp & Dohme Ltd. is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 01.07.2010 - Priority Date (US 20100360626P)
  • 05.01.2012 - Publication A1 (WO2012003147)
  • 08.05.2013 - Publication A1 (EP2588104)
  • 10.12.2014 - Publication B1 (EP2588104)